The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antibodies Contract Manufacturing Market Research Report 2025
Synopsis
The global Antibodies Contract Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Antibodies Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antibodies Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Antibodies Contract Manufacturing in SME is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Antibodies Contract Manufacturing include AMRI, AGC Biologics, Aldevron, Eurofins CDMO, Boehringer Ingelheim BioXcellence, FUJIFILM Diosynth Biotechnologies, Emergent BioSolutions, KBI Biopharma and Lonza, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antibodies Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibodies Contract Manufacturing.
Report Scope
The Antibodies Contract Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibodies Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibodies Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AMRI
AGC Biologics
Aldevron
Eurofins CDMO
Boehringer Ingelheim BioXcellence
FUJIFILM Diosynth Biotechnologies
Emergent BioSolutions
KBI Biopharma
Lonza
Novasep
Nitto Avecia Pharma Services
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific
Segment by Type
Monoclonal Antibodies
Antibody Fragments
Polyclonal Antibodies
Segment by Application
SME
Large Enterprise
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibodies Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Antibodies Contract Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Antibodies Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antibodies Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Antibodies Contract Manufacturing in SME is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Antibodies Contract Manufacturing include AMRI, AGC Biologics, Aldevron, Eurofins CDMO, Boehringer Ingelheim BioXcellence, FUJIFILM Diosynth Biotechnologies, Emergent BioSolutions, KBI Biopharma and Lonza, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antibodies Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibodies Contract Manufacturing.
Report Scope
The Antibodies Contract Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibodies Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibodies Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AMRI
AGC Biologics
Aldevron
Eurofins CDMO
Boehringer Ingelheim BioXcellence
FUJIFILM Diosynth Biotechnologies
Emergent BioSolutions
KBI Biopharma
Lonza
Novasep
Nitto Avecia Pharma Services
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific
Segment by Type
Monoclonal Antibodies
Antibody Fragments
Polyclonal Antibodies
Segment by Application
SME
Large Enterprise
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibodies Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibodies Contract Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Antibody Fragments
1.2.4 Polyclonal Antibodies
1.3 Market by Application
1.3.1 Global Antibodies Contract Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SME
1.3.3 Large Enterprise
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibodies Contract Manufacturing Market Perspective (2019-2030)
2.2 Antibodies Contract Manufacturing Growth Trends by Region
2.2.1 Global Antibodies Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antibodies Contract Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Antibodies Contract Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Antibodies Contract Manufacturing Market Dynamics
2.3.1 Antibodies Contract Manufacturing Industry Trends
2.3.2 Antibodies Contract Manufacturing Market Drivers
2.3.3 Antibodies Contract Manufacturing Market Challenges
2.3.4 Antibodies Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibodies Contract Manufacturing Players by Revenue
3.1.1 Global Top Antibodies Contract Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Antibodies Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Antibodies Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibodies Contract Manufacturing Revenue
3.4 Global Antibodies Contract Manufacturing Market Concentration Ratio
3.4.1 Global Antibodies Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibodies Contract Manufacturing Revenue in 2023
3.5 Antibodies Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Antibodies Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Antibodies Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibodies Contract Manufacturing Breakdown Data by Type
4.1 Global Antibodies Contract Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Antibodies Contract Manufacturing Forecasted Market Size by Type (2025-2030)
5 Antibodies Contract Manufacturing Breakdown Data by Application
5.1 Global Antibodies Contract Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Antibodies Contract Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antibodies Contract Manufacturing Market Size (2019-2030)
6.2 North America Antibodies Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antibodies Contract Manufacturing Market Size by Country (2019-2024)
6.4 North America Antibodies Contract Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibodies Contract Manufacturing Market Size (2019-2030)
7.2 Europe Antibodies Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antibodies Contract Manufacturing Market Size by Country (2019-2024)
7.4 Europe Antibodies Contract Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibodies Contract Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Antibodies Contract Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antibodies Contract Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Antibodies Contract Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibodies Contract Manufacturing Market Size (2019-2030)
9.2 Latin America Antibodies Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antibodies Contract Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Antibodies Contract Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibodies Contract Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Antibodies Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antibodies Contract Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Antibodies Contract Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AMRI
11.1.1 AMRI Company Detail
11.1.2 AMRI Business Overview
11.1.3 AMRI Antibodies Contract Manufacturing Introduction
11.1.4 AMRI Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.1.5 AMRI Recent Development
11.2 AGC Biologics
11.2.1 AGC Biologics Company Detail
11.2.2 AGC Biologics Business Overview
11.2.3 AGC Biologics Antibodies Contract Manufacturing Introduction
11.2.4 AGC Biologics Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.2.5 AGC Biologics Recent Development
11.3 Aldevron
11.3.1 Aldevron Company Detail
11.3.2 Aldevron Business Overview
11.3.3 Aldevron Antibodies Contract Manufacturing Introduction
11.3.4 Aldevron Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.3.5 Aldevron Recent Development
11.4 Eurofins CDMO
11.4.1 Eurofins CDMO Company Detail
11.4.2 Eurofins CDMO Business Overview
11.4.3 Eurofins CDMO Antibodies Contract Manufacturing Introduction
11.4.4 Eurofins CDMO Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.4.5 Eurofins CDMO Recent Development
11.5 Boehringer Ingelheim BioXcellence
11.5.1 Boehringer Ingelheim BioXcellence Company Detail
11.5.2 Boehringer Ingelheim BioXcellence Business Overview
11.5.3 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Introduction
11.5.4 Boehringer Ingelheim BioXcellence Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.5.5 Boehringer Ingelheim BioXcellence Recent Development
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.6.3 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Introduction
11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.7 Emergent BioSolutions
11.7.1 Emergent BioSolutions Company Detail
11.7.2 Emergent BioSolutions Business Overview
11.7.3 Emergent BioSolutions Antibodies Contract Manufacturing Introduction
11.7.4 Emergent BioSolutions Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.7.5 Emergent BioSolutions Recent Development
11.8 KBI Biopharma
11.8.1 KBI Biopharma Company Detail
11.8.2 KBI Biopharma Business Overview
11.8.3 KBI Biopharma Antibodies Contract Manufacturing Introduction
11.8.4 KBI Biopharma Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.8.5 KBI Biopharma Recent Development
11.9 Lonza
11.9.1 Lonza Company Detail
11.9.2 Lonza Business Overview
11.9.3 Lonza Antibodies Contract Manufacturing Introduction
11.9.4 Lonza Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.9.5 Lonza Recent Development
11.10 Novasep
11.10.1 Novasep Company Detail
11.10.2 Novasep Business Overview
11.10.3 Novasep Antibodies Contract Manufacturing Introduction
11.10.4 Novasep Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.10.5 Novasep Recent Development
11.11 Nitto Avecia Pharma Services
11.11.1 Nitto Avecia Pharma Services Company Detail
11.11.2 Nitto Avecia Pharma Services Business Overview
11.11.3 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Introduction
11.11.4 Nitto Avecia Pharma Services Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.11.5 Nitto Avecia Pharma Services Recent Development
11.12 Pierre Fabre
11.12.1 Pierre Fabre Company Detail
11.12.2 Pierre Fabre Business Overview
11.12.3 Pierre Fabre Antibodies Contract Manufacturing Introduction
11.12.4 Pierre Fabre Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.12.5 Pierre Fabre Recent Development
11.13 Samsung BioLogics
11.13.1 Samsung BioLogics Company Detail
11.13.2 Samsung BioLogics Business Overview
11.13.3 Samsung BioLogics Antibodies Contract Manufacturing Introduction
11.13.4 Samsung BioLogics Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.13.5 Samsung BioLogics Recent Development
11.14 Synthon
11.14.1 Synthon Company Detail
11.14.2 Synthon Business Overview
11.14.3 Synthon Antibodies Contract Manufacturing Introduction
11.14.4 Synthon Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.14.5 Synthon Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Detail
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Antibodies Contract Manufacturing Introduction
11.15.4 Thermo Fisher Scientific Revenue in Antibodies Contract Manufacturing Business (2019-2024)
11.15.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Antibodies Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Antibody Fragments
Table 4. Key Players of Polyclonal Antibodies
Table 5. Global Antibodies Contract Manufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antibodies Contract Manufacturing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Antibodies Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Antibodies Contract Manufacturing Market Share by Region (2019-2024)
Table 9. Global Antibodies Contract Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Antibodies Contract Manufacturing Market Share by Region (2025-2030)
Table 11. Antibodies Contract Manufacturing Market Trends
Table 12. Antibodies Contract Manufacturing Market Drivers
Table 13. Antibodies Contract Manufacturing Market Challenges
Table 14. Antibodies Contract Manufacturing Market Restraints
Table 15. Global Antibodies Contract Manufacturing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Antibodies Contract Manufacturing Market Share by Players (2019-2024)
Table 17. Global Top Antibodies Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibodies Contract Manufacturing as of 2023)
Table 18. Ranking of Global Top Antibodies Contract Manufacturing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Antibodies Contract Manufacturing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antibodies Contract Manufacturing Product Solution and Service
Table 22. Date of Enter into Antibodies Contract Manufacturing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibodies Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Antibodies Contract Manufacturing Revenue Market Share by Type (2019-2024)
Table 26. Global Antibodies Contract Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Antibodies Contract Manufacturing Revenue Market Share by Type (2025-2030)
Table 28. Global Antibodies Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Antibodies Contract Manufacturing Revenue Market Share by Application (2019-2024)
Table 30. Global Antibodies Contract Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Antibodies Contract Manufacturing Revenue Market Share by Application (2025-2030)
Table 32. North America Antibodies Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Antibodies Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Antibodies Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Antibodies Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Antibodies Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Antibodies Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Antibodies Contract Manufacturing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Antibodies Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Antibodies Contract Manufacturing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Antibodies Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Antibodies Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Antibodies Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Antibodies Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Antibodies Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Antibodies Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 47. AMRI Company Detail
Table 48. AMRI Business Overview
Table 49. AMRI Antibodies Contract Manufacturing Product
Table 50. AMRI Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 51. AMRI Recent Development
Table 52. AGC Biologics Company Detail
Table 53. AGC Biologics Business Overview
Table 54. AGC Biologics Antibodies Contract Manufacturing Product
Table 55. AGC Biologics Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 56. AGC Biologics Recent Development
Table 57. Aldevron Company Detail
Table 58. Aldevron Business Overview
Table 59. Aldevron Antibodies Contract Manufacturing Product
Table 60. Aldevron Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 61. Aldevron Recent Development
Table 62. Eurofins CDMO Company Detail
Table 63. Eurofins CDMO Business Overview
Table 64. Eurofins CDMO Antibodies Contract Manufacturing Product
Table 65. Eurofins CDMO Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 66. Eurofins CDMO Recent Development
Table 67. Boehringer Ingelheim BioXcellence Company Detail
Table 68. Boehringer Ingelheim BioXcellence Business Overview
Table 69. Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Product
Table 70. Boehringer Ingelheim BioXcellence Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 71. Boehringer Ingelheim BioXcellence Recent Development
Table 72. FUJIFILM Diosynth Biotechnologies Company Detail
Table 73. FUJIFILM Diosynth Biotechnologies Business Overview
Table 74. FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Product
Table 75. FUJIFILM Diosynth Biotechnologies Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 76. FUJIFILM Diosynth Biotechnologies Recent Development
Table 77. Emergent BioSolutions Company Detail
Table 78. Emergent BioSolutions Business Overview
Table 79. Emergent BioSolutions Antibodies Contract Manufacturing Product
Table 80. Emergent BioSolutions Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 81. Emergent BioSolutions Recent Development
Table 82. KBI Biopharma Company Detail
Table 83. KBI Biopharma Business Overview
Table 84. KBI Biopharma Antibodies Contract Manufacturing Product
Table 85. KBI Biopharma Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 86. KBI Biopharma Recent Development
Table 87. Lonza Company Detail
Table 88. Lonza Business Overview
Table 89. Lonza Antibodies Contract Manufacturing Product
Table 90. Lonza Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 91. Lonza Recent Development
Table 92. Novasep Company Detail
Table 93. Novasep Business Overview
Table 94. Novasep Antibodies Contract Manufacturing Product
Table 95. Novasep Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 96. Novasep Recent Development
Table 97. Nitto Avecia Pharma Services Company Detail
Table 98. Nitto Avecia Pharma Services Business Overview
Table 99. Nitto Avecia Pharma Services Antibodies Contract Manufacturing Product
Table 100. Nitto Avecia Pharma Services Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 101. Nitto Avecia Pharma Services Recent Development
Table 102. Pierre Fabre Company Detail
Table 103. Pierre Fabre Business Overview
Table 104. Pierre Fabre Antibodies Contract Manufacturing Product
Table 105. Pierre Fabre Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 106. Pierre Fabre Recent Development
Table 107. Samsung BioLogics Company Detail
Table 108. Samsung BioLogics Business Overview
Table 109. Samsung BioLogics Antibodies Contract Manufacturing Product
Table 110. Samsung BioLogics Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 111. Samsung BioLogics Recent Development
Table 112. Synthon Company Detail
Table 113. Synthon Business Overview
Table 114. Synthon Antibodies Contract Manufacturing Product
Table 115. Synthon Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 116. Synthon Recent Development
Table 117. Thermo Fisher Scientific Company Detail
Table 118. Thermo Fisher Scientific Business Overview
Table 119. Thermo Fisher Scientific Antibodies Contract Manufacturing Product
Table 120. Thermo Fisher Scientific Revenue in Antibodies Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 121. Thermo Fisher Scientific Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibodies Contract Manufacturing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antibodies Contract Manufacturing Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Antibody Fragments Features
Figure 5. Polyclonal Antibodies Features
Figure 6. Global Antibodies Contract Manufacturing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Antibodies Contract Manufacturing Market Share by Application: 2023 VS 2030
Figure 8. SME Case Studies
Figure 9. Large Enterprise Case Studies
Figure 10. Antibodies Contract Manufacturing Report Years Considered
Figure 11. Global Antibodies Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Antibodies Contract Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Antibodies Contract Manufacturing Market Share by Region: 2023 VS 2030
Figure 14. Global Antibodies Contract Manufacturing Market Share by Players in 2023
Figure 15. Global Top Antibodies Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibodies Contract Manufacturing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Antibodies Contract Manufacturing Revenue in 2023
Figure 17. North America Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Antibodies Contract Manufacturing Market Share by Country (2019-2030)
Figure 19. United States Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Antibodies Contract Manufacturing Market Share by Country (2019-2030)
Figure 23. Germany Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Antibodies Contract Manufacturing Market Share by Region (2019-2030)
Figure 31. China Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Antibodies Contract Manufacturing Market Share by Country (2019-2030)
Figure 39. Mexico Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Antibodies Contract Manufacturing Market Share by Country (2019-2030)
Figure 43. Turkey Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Antibodies Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. AMRI Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 46. AGC Biologics Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 47. Aldevron Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 48. Eurofins CDMO Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 49. Boehringer Ingelheim BioXcellence Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 50. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 51. Emergent BioSolutions Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 52. KBI Biopharma Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 53. Lonza Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 54. Novasep Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 55. Nitto Avecia Pharma Services Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 56. Pierre Fabre Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 57. Samsung BioLogics Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 58. Synthon Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Antibodies Contract Manufacturing Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
